In June, medical providers worldwide begin grappling with how to address a growing shortage of the isotope molybdenum-99, which is used to create imaging contrast materials, when Canada’s Chalk River nuclear reactor shut down indefinitely and several other reactors around the world closed for repairs and maintenance. The shortages caused long-running delays in needed imaging procedures. In October, President Barack Obama signs legislation allocating $20 million to jump-start the creation of a domestic medical isotope supply, and in November, the U.S. House passes the American Medical Isotopes Production Act of 2009, which would allocate $163 million to support the production of medical isotopes within the U.S.
Isotope shortage prompts action
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.